237 related articles for article (PubMed ID: 17926376)
1. Pelvic exenteration for carcinoma of the cervix.
Ingersoll FM; Ulfelder H
N Engl J Med; 1966 Mar; 274(12):648-51. PubMed ID: 17926376
[TBL] [Abstract][Full Text] [Related]
2. [Pelvic exenteration for carcinoma of the uterine cervix (author's transl)].
Mayer M; Bobin JY; Colon J; Borg G
Bull Cancer; 1980; 67(1):70-7. PubMed ID: 7362891
[TBL] [Abstract][Full Text] [Related]
3. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
4. Pelvic exenteration for adenocarcinoma of the uterine cervix.
Crozier M; Morris M; Levenback C; Lucas KR; Atkinson EN; Wharton JT
Gynecol Oncol; 1995 Jul; 58(1):74-8. PubMed ID: 7789894
[TBL] [Abstract][Full Text] [Related]
5. Pelvic exenteration. Has it a role in 1987? A six year experience.
Shepherd JH
Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684
[TBL] [Abstract][Full Text] [Related]
6. Cecal rupture after continent ileocecal urinary diversion during total pelvic exenteration.
Brand E
Obstet Gynecol; 1991 Sep; 78(3 Pt 2):570-2. PubMed ID: 1870828
[TBL] [Abstract][Full Text] [Related]
7. [Pelvic exenteration, morbidity and survival].
Méndez L; Bernal A; Escudero P; González G; Fajardo A
Ginecol Obstet Mex; 1994 Jun; 62():161-5. PubMed ID: 8056362
[TBL] [Abstract][Full Text] [Related]
8. Major morbidity after pelvic exenteration: a seven-year experience.
Roberts WS; Cavanagh D; Bryson SC; Lyman GH; Hewitt S
Obstet Gynecol; 1987 Apr; 69(4):617-21. PubMed ID: 3822305
[TBL] [Abstract][Full Text] [Related]
9. Primary pelvic exenteration in cervical cancer patients.
Ungar L; Palfalvi L; Novak Z
Gynecol Oncol; 2008 Nov; 111(2 Suppl):S9-12. PubMed ID: 18775558
[TBL] [Abstract][Full Text] [Related]
10. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan.
Maggioni A; Roviglione G; Landoni F; Zanagnolo V; Peiretti M; Colombo N; Bocciolone L; Biffi R; Minig L; Morrow CP
Gynecol Oncol; 2009 Jul; 114(1):64-8. PubMed ID: 19411097
[TBL] [Abstract][Full Text] [Related]
11. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer.
Schmidt AM; Imesch P; Fink D; Egger H
Gynecol Oncol; 2012 Jun; 125(3):604-9. PubMed ID: 22406639
[TBL] [Abstract][Full Text] [Related]
12. Ileal orthotopic neobladder after pelvic exenteration for cervical cancer.
Chiva LM; Lapuente F; Núñez C; Ramírez PT
Gynecol Oncol; 2009 Apr; 113(1):47-51. PubMed ID: 19176235
[TBL] [Abstract][Full Text] [Related]
13. Conservative surgery for recurrent or persistent carcinoma of the cervix following irradiation: is exenteration always necessary?
Rutledge S; Carey MS; Prichard H; Allen HH; Kocha W; Kirk ME
Gynecol Oncol; 1994 Mar; 52(3):353-9. PubMed ID: 8157192
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic pelvic exenteration for advanced pelvic cancers: a review of 16 cases.
Puntambekar S; Kudchadkar RJ; Gurjar AM; Sathe RM; Chaudhari YC; Agarwal GA; Rayate NV
Gynecol Oncol; 2006 Sep; 102(3):513-6. PubMed ID: 16510172
[TBL] [Abstract][Full Text] [Related]
15. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
[TBL] [Abstract][Full Text] [Related]
16. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients.
Houvenaeghel G; Moutardier V; Karsenty G; Bladou F; Lelong B; Buttarelli M; Delpero JR
Gynecol Oncol; 2004 Feb; 92(2):680-3. PubMed ID: 14766266
[TBL] [Abstract][Full Text] [Related]
17. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
[TBL] [Abstract][Full Text] [Related]
18. Pelvic exenteration: a perspective from a regional cancer center in India.
Pandey D; Zaidi S; Mahajan V; Kannan R
Indian J Cancer; 2004; 41(3):109-14. PubMed ID: 15472408
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of ureteral obstruction in patients with recurrent carcinoma of the cervix uteri.
Van Dyke AH; Van Nagell JR
Surg Gynecol Obstet; 1975 Sep; 141(3):371-3. PubMed ID: 1162563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
